New PET scanner versus standard PET for head and neck imaging
Part of Brain & nervous system, Cancer, Hormones & metabolism, Mental health clinical trials.
This study compares a newer PET/CT scanner (called NeuroEXPLORER) with standard PET/CT scanners for imaging the head and neck region. The goal is to see if the new scanner provides better or clearer images to help diagnose conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been referred by your doctor for a standard PET scan of your head and neck
- You are willing to avoid intense or unusual physical activity for 5 days (4 days before and 1 day after the scan)
- You understand the study procedures and are able to complete all required tests
- You have not had more than one other research PET or CT scan in the past 12 months
- You agree that any unexpected findings will be shared with your doctor and yourself
- You are able to give informed consent (or have a legal representative if needed for certain substudies)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new ultra-high resolution PET scanner to look at brain changes in healthy aging, dementia, ALS, movement disorders, and psychosis. It aims to better understand these conditions and improve imaging techniques.
This trial uses advanced PET and MR scans to better understand and diagnose brain diseases like Alzheimer's, Parkinson's, epilepsy, and brain tumors. It may help identify new ways to track these conditions.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
This early-phase study tests a new PET scan tracer that targets a brain chemical transport system involved in dementia. It aims to see if the tracer can safely and clearly show brain changes, which could help future dementia diagnosis or tracking.
This trial tests a new PET/CT imaging method that uses two different tracers at the same time to better see cancers and Parkinson's syndrome. It may help doctors find and monitor disease more accurately.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.